Literature DB >> 8465394

Serum ionized calcium, serum and intracellular phosphate, and serum parathormone concentrations in acute malaria.

T M Davis1, G Q Li, X B Guo, J L Spencer, A St John.   

Abstract

Previous studies have shown depressed serum corrected calcium and phosphate concentrations in acute falciparum malaria. To characterize malaria-associated disturbances in mineral homoeostasis further, serum ionized calcium and intracellular phosphate were measured in 18 patients (10 with falciparum malaria, 8 with vivax malaria) and 10 healthy controls. Six patients (4 falciparum, 2 vivax) had admission serum ionized calcium concentrations below the absolute control range (< 1.15 mmol/litre) and a further six (3 falciparum, 3 vivax) developed ionized hypocalcaemia during treatment. The patients with falciparum malaria had the lowest values at presentation (median [95% confidence intervals in brackets]: 1.17 [1.12-1.23] vs. 1.20 [1.18-1.24] mmol/litre in controls, P = 0.035) in the presence of depressed simultaneous serum parathormone concentrations (1.2 [0.6-1.9] vs. 1.6 [1.1-2.6] pmol/litre; P = 0.05). Admission serum phosphate concentrations were lower in the malaria patients (P = 0.007 vs. controls), especially in those with falciparum malaria (0.85 [0.7-1.1] vs. 1.2 [1.1-1.3] mmol/litre in controls; P = 0.002); patients with falciparum malaria also had significantly lower intracellular phosphate than controls (0.74 [0.58-0.90] vs. 0.88 [0.66-1.04] mmol/litre red cells; P = 0.047). There was a weak association between serum corrected and ionized calcium in the malaria patients (rs = 0.31, n = 18, P > 0.1), but serum and intracellular phosphate correlated significantly (rs = 0.71, n = 17, P < 0.001) with a regression line slope of 0.49 and intercept of 0.27 mmol/litre of red cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8465394     DOI: 10.1016/0035-9203(93)90416-n

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.

Authors:  B R Moore; J M Benjamin; S Salman; S Griffin; E Ginny; M Page-Sharp; L J Robinson; P Siba; K T Batty; I Mueller; T M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

2.  Cerebral Malaria: An Unusual Cause of Central Diabetes Insipidus.

Authors:  Resmi Premji; Nira Roopnarinesingh; Joshua Cohen; Sabyasachi Sen
Journal:  Case Rep Endocrinol       Date:  2016-05-08

3.  Safety profile of L-arginine infusion in moderately severe falciparum malaria.

Authors:  Tsin W Yeo; Daniel A Lampah; Retno Gitawati; Emiliana Tjitra; Enny Kenangalem; Donald L Granger; J Brice Weinberg; Bert K Lopansri; Ric N Price; David S Celermajer; Stephen B Duffull; Nicholas M Anstey
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

4.  Dissecting the catalytic mechanism of Trypanosoma brucei trypanothione synthetase by kinetic analysis and computational modeling.

Authors:  Alejandro E Leroux; Jurgen R Haanstra; Barbara M Bakker; R Luise Krauth-Siegel
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.